Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization

American Heart Journal

Volumn 152, Issue 2, 2006, Pages 290.e1-290.e7

  Foo, Shi Yin ^a   Everett, Brendan M ^a   Yeh, Robert W ^a   Criss, David ^a   Laposata, Michael ^a   Van Cott, Elizabeth M ^a   Jang, Ik Kyung ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; BLEEDING; CARDIAC PATIENT; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; HEART CATHETERIZATION; HUMAN; HYPERCOAGULABILITY; IMMUNOASSAY; INTERVIEW; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; TELEPHONE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; TIME;

EID: 33746266580     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.04.028     Document Type: Article

References (12)

1. Fahey V.A. Heparin-induced thrombocytopenia. J Vasc Nurs 13 (1995) 112-116
2. Campbell K.R., Mahaffey K.W., Lewis B.F., et al. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J Invasc Cardiol 12 Suppl F (2000) 14F-19F
3. Warkentin T.E., Sheppard J.I., Horsewood P., et al. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96 (2000) 1703-1708
4. Warkentin T.E., and Kelton J.G. A 14 year study of heparin-induced thrombocytopenia. Am J Med 101 (1996) 502-507
5. Wallis D.E., Workman D.L., Lewis B.E., et al. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 106 (1999) 629-635
6. Lewis B.E., Wallis D.E., Leya F., et al. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Int Med 163 (2003) 1849-1856
7. Hirsh J., Heddle N., and Kelton J.G. Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med 164 (2004) 361-369
8. Williams R.T., Damaraju L.V., Mascelli M.A., et al. Anti-platelet factor 4/heparin antibodies; an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes. Circulation (2003) 2307-2312
9. Mattioli A.V., Bonetti L., Sternieri S., et al. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up. Ital Heart J 1 (2000) 39-42
10. Fabris F., Luzzatto G., Soini B., et al. Risk factors for thrombosis in patients with immune-mediated heparin-induced thrombocytopenia. J Int Med 252 (2002) 149-154
11. Bauer T.L., Arepally G., Konkle B.A., et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 95 (1997) 1242-1246
12. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76 (2003) 2121-2131